| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |